Huntington National Bank’s Acceleron Pharma XLRN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $358 | Hold |
2
| – | – | ﹤0.01% | 2466 |
|
|
2025
Q4 | $358 | Hold |
2
| – | – | ﹤0.01% | 2386 |
|
|
2025
Q3 | $358 | Hold |
2
| – | – | ﹤0.01% | 2452 |
|
|
2025
Q2 | $358 | Hold |
2
| – | – | ﹤0.01% | 2500 |
|
|
2025
Q1 | $358 | Hold |
2
| – | – | ﹤0.01% | 2521 |
|
|
2024
Q4 | $358 | Hold |
2
| – | – | ﹤0.01% | 2561 |
|
|
2024
Q3 | $358 | Hold |
2
| – | – | ﹤0.01% | 2548 |
|
|
2024
Q2 | $358 | Hold |
2
| – | – | ﹤0.01% | 2485 |
|
|
2024
Q1 | $358 | Hold |
2
| – | – | ﹤0.01% | 2379 |
|
|
2023
Q4 | $358 | Hold |
2
| – | – | ﹤0.01% | 2313 |
|
|
2023
Q3 | $358 | Hold |
2
| – | – | ﹤0.01% | 2288 |
|
|
2023
Q2 | $358 | Hold |
2
| – | – | ﹤0.01% | 2248 |
|
|
2023
Q1 | $358 | Hold |
2
| – | – | ﹤0.01% | 2105 |
|
|
2022
Q4 | $358 | Hold |
2
| – | – | ﹤0.01% | 1956 |
|
|
2022
Q3 | $0 | Hold |
2
| – | – | ﹤0.01% | 2565 |
|
|
2022
Q2 | $0 | Hold |
2
| – | – | ﹤0.01% | 2571 |
|
|
2022
Q1 | $0 | Hold |
2
| – | – | ﹤0.01% | 2497 |
|
|
2021
Q4 | $0 | Sell |
2
-55
| -96% | -$9.59K | ﹤0.01% | 2421 |
|
|
2021
Q3 | $10K | Hold |
57
| – | – | ﹤0.01% | 1465 |
|
|
2021
Q2 | $7K | Buy |
+57
| New | +$7.19K | ﹤0.01% | 1518 |
|
Huntington National Bank's XLRN Position: Q1 2026 in Review
Huntington National Bank held its Acceleron Pharma (XLRN) position steady in Q1 2026 at 2 shares worth $358. The position accounts for ﹤0.01% of the portfolio, ranked #2466.
Huntington National Bank first reported a position in XLRN in Q2 2021 and has held it in 20 quarters since. The position peaked at $10K in Q3 2021. 1 fund tracked by Wall St. Rank holds XLRN as of Q1 2026.
- Huntington National Bank held 2 shares of Acceleron Pharma worth $358 as of Q1 2026.
- Huntington National Bank left its Acceleron Pharma share count unchanged in Q1 2026.
- Acceleron Pharma made up ﹤0.01% of Huntington National Bank's portfolio in Q1 2026, its #2466 holding.
- Huntington National Bank first reported a position in Acceleron Pharma in Q2 2021 and has held it in 20 quarters since.
- Huntington National Bank's Acceleron Pharma position peaked at $10K in Q3 2021.
- 1 fund tracked by Wall St. Rank held Acceleron Pharma as of Q1 2026.
Based on Huntington National Bank's 13F filing for Q1 2026, filed 15 May 2026.